Cargando…
Inducible nitric oxide synthase deficiency promotes murine-β-coronavirus induced demyelination
BACKGROUND: Multiple sclerosis (MS) is characterized by neuroinflammation and demyelination orchestrated by activated neuroglial cells, CNS infiltrating leukocytes, and their reciprocal interactions through inflammatory signals. An inflammatory stimulus triggers inducible nitric oxide synthase (NOS2...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039690/ https://www.ncbi.nlm.nih.gov/pubmed/36966345 http://dx.doi.org/10.1186/s12985-023-02006-1 |
_version_ | 1784912323676209152 |
---|---|
author | Kamble, Mithila Saadi, Fareeha Kumar, Saurav Saha, Bhaskar Das Sarma, Jayasri |
author_facet | Kamble, Mithila Saadi, Fareeha Kumar, Saurav Saha, Bhaskar Das Sarma, Jayasri |
author_sort | Kamble, Mithila |
collection | PubMed |
description | BACKGROUND: Multiple sclerosis (MS) is characterized by neuroinflammation and demyelination orchestrated by activated neuroglial cells, CNS infiltrating leukocytes, and their reciprocal interactions through inflammatory signals. An inflammatory stimulus triggers inducible nitric oxide synthase (NOS2), a pro-inflammatory marker of microglia/macrophages (MG/Mφ) to catalyze sustained nitric oxide production. NOS2 during neuroinflammation, has been associated with MS disease pathology; however, studies dissecting its role in demyelination are limited. We studied the role of NOS2 in a recombinant β-coronavirus-MHV-RSA59 induced neuroinflammation, an experimental animal model mimicking the pathological hallmarks of MS: neuroinflammatory demyelination and axonal degeneration. OBJECTIVE: Understanding the role of NOS2 in murine-β-coronavirus-MHV-RSA59 demyelination. METHODS: Brain and spinal cords from mock and RSA59 infected 4–5-week-old MHV-free C57BL/6 mice (WT) and NOS2-/- mice were harvested at different disease phases post infection (p.i.) (day 5/6-acute, day 9/10-acute-adaptive and day 30-chronic phase) and compared for pathological outcomes. RESULTS: NOS2 was upregulated at the acute phase of RSA59-induced disease in WT mice and its deficiency resulted in severe disease and reduced survival at the acute-adaptive transition phase. Low survival in NOS2-/- mice was attributed to (i) high neuroinflammation resulting from increased accumulation of macrophages and neutrophils and (ii) Iba1 + phagocytic MG/Mφ mediated-early demyelination as observed at this phase. The phagocytic phenotype of CNS MG/Mφ was confirmed by significantly higher mRNA transcripts of phagocyte markers-CD206, TREM2, and Arg1 and double immunolabelling of Iba1 with MBP and PLP. Further, NOS2 deficiency led to exacerbated demyelination at the chronic phase as well. CONCLUSION: Taken together the results imply that the immune system failed to control the disease progression in the absence of NOS2. Thus, our observations highlight a protective role of NOS2 in murine-β-coronavirus induced demyelination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-023-02006-1. |
format | Online Article Text |
id | pubmed-10039690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100396902023-03-27 Inducible nitric oxide synthase deficiency promotes murine-β-coronavirus induced demyelination Kamble, Mithila Saadi, Fareeha Kumar, Saurav Saha, Bhaskar Das Sarma, Jayasri Virol J Research BACKGROUND: Multiple sclerosis (MS) is characterized by neuroinflammation and demyelination orchestrated by activated neuroglial cells, CNS infiltrating leukocytes, and their reciprocal interactions through inflammatory signals. An inflammatory stimulus triggers inducible nitric oxide synthase (NOS2), a pro-inflammatory marker of microglia/macrophages (MG/Mφ) to catalyze sustained nitric oxide production. NOS2 during neuroinflammation, has been associated with MS disease pathology; however, studies dissecting its role in demyelination are limited. We studied the role of NOS2 in a recombinant β-coronavirus-MHV-RSA59 induced neuroinflammation, an experimental animal model mimicking the pathological hallmarks of MS: neuroinflammatory demyelination and axonal degeneration. OBJECTIVE: Understanding the role of NOS2 in murine-β-coronavirus-MHV-RSA59 demyelination. METHODS: Brain and spinal cords from mock and RSA59 infected 4–5-week-old MHV-free C57BL/6 mice (WT) and NOS2-/- mice were harvested at different disease phases post infection (p.i.) (day 5/6-acute, day 9/10-acute-adaptive and day 30-chronic phase) and compared for pathological outcomes. RESULTS: NOS2 was upregulated at the acute phase of RSA59-induced disease in WT mice and its deficiency resulted in severe disease and reduced survival at the acute-adaptive transition phase. Low survival in NOS2-/- mice was attributed to (i) high neuroinflammation resulting from increased accumulation of macrophages and neutrophils and (ii) Iba1 + phagocytic MG/Mφ mediated-early demyelination as observed at this phase. The phagocytic phenotype of CNS MG/Mφ was confirmed by significantly higher mRNA transcripts of phagocyte markers-CD206, TREM2, and Arg1 and double immunolabelling of Iba1 with MBP and PLP. Further, NOS2 deficiency led to exacerbated demyelination at the chronic phase as well. CONCLUSION: Taken together the results imply that the immune system failed to control the disease progression in the absence of NOS2. Thus, our observations highlight a protective role of NOS2 in murine-β-coronavirus induced demyelination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-023-02006-1. BioMed Central 2023-03-25 /pmc/articles/PMC10039690/ /pubmed/36966345 http://dx.doi.org/10.1186/s12985-023-02006-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kamble, Mithila Saadi, Fareeha Kumar, Saurav Saha, Bhaskar Das Sarma, Jayasri Inducible nitric oxide synthase deficiency promotes murine-β-coronavirus induced demyelination |
title | Inducible nitric oxide synthase deficiency promotes murine-β-coronavirus induced demyelination |
title_full | Inducible nitric oxide synthase deficiency promotes murine-β-coronavirus induced demyelination |
title_fullStr | Inducible nitric oxide synthase deficiency promotes murine-β-coronavirus induced demyelination |
title_full_unstemmed | Inducible nitric oxide synthase deficiency promotes murine-β-coronavirus induced demyelination |
title_short | Inducible nitric oxide synthase deficiency promotes murine-β-coronavirus induced demyelination |
title_sort | inducible nitric oxide synthase deficiency promotes murine-β-coronavirus induced demyelination |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039690/ https://www.ncbi.nlm.nih.gov/pubmed/36966345 http://dx.doi.org/10.1186/s12985-023-02006-1 |
work_keys_str_mv | AT kamblemithila induciblenitricoxidesynthasedeficiencypromotesmurinebcoronavirusinduceddemyelination AT saadifareeha induciblenitricoxidesynthasedeficiencypromotesmurinebcoronavirusinduceddemyelination AT kumarsaurav induciblenitricoxidesynthasedeficiencypromotesmurinebcoronavirusinduceddemyelination AT sahabhaskar induciblenitricoxidesynthasedeficiencypromotesmurinebcoronavirusinduceddemyelination AT dassarmajayasri induciblenitricoxidesynthasedeficiencypromotesmurinebcoronavirusinduceddemyelination |